Acute Treatment of Vestibular Migraine by Rimegepant

Study acronym: VM-rime
StatusRecruiting
PhasePhase 4
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
Wensheng Qu
1 trial monitored
See all monitored trials
Migraine
483 trials monitored
See 27 trials at risk
To evaluate whether rimegepant improves acute vestibular symptoms and accompanying discomforts in patients with vestibular migraine.
Trial Details
NCT Number NCT07871097
Lead Sponsor Wensheng Qu
Collaborators: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan No.1 Hospital, Wuhan Puren Hospital, Xiangyang Central Hospital, Xinyang Central Hospital
Conditions
(from sponsor)		 Vestibular Migraine
Enrollment 80 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov